Quantitative Analytics

Nex Rubica's Indexes & Ratings team has been the leading provider of Pan African securities pricing, financial information, risk ratings, and analytic tools to institutional and individual investors. The company supplies pricing (including evaluated pricing), dividend, corporate action, and descriptive information for more than 900 securities traded in Africa, including hard-to-value investments. The risk map we provide also determines the extent to which a company minimizes recognized risks and maximizes asset safety for investors. The overall risk (default) rating we assign to a company listed on our Africa 40 or 100 basket is based on our assessment of Liquidity, Credit, Market, Operational and Asset commitment risk. NR Indexes data is published in Bloomberg, Reuters and various other editorial magazines like Forbes and Euromoney's Global Investor.

Our Goal

NR's Indexes products will continually gain wider acceptance as more large institutional investors use the Index to evaluate their managers' (research staff and analyst) performance.

NR's Indexes will offer objectivity and realism through a methodology carefully developed with indigenous firms in mind. What will make NR Indexes effective isn't just its breadth of coverage or the methodology we use, but our understanding of the corporate culture and risks in Emerging Markets.

The initial impetus for NR Indexes to create its own African index series was the need for a quantitative means of telling the story of daily securities trading around the continent.

Not only would the indices be weighted by market capitalization, but also the geographic groupings of countries and regions would be complemented by a more detailed breakdown of economic sectors and industry groups than was available from other index providers. For more see our FAQ document.

For example, to accurately reflect market activity, NR Indexes will represent only stocks that are likely to be traded. NR Indexes provides state-of-the-art performance measurement tools and risk analyses.

FAQ

See our FAQ